The Indiana House bill is key to providing women quicker access to contraceptives, bill sponsor Republican Sen. Sue Glick said Tuesday, especially in areas where they struggle to receive primary care.
Read More
Drugstore chains are still trying to find enough employees to put a stop to temporary pharmacy closures.
Read More
CVS and Walgreens have agreed to pay state and local governments a combined total of more than $10 billion to settle lawsuits over the toll of opioids.
Read More
While they scramble to fill positions, some pharmacies are cutting their hours or closing locations. That means patients are waiting longer to get their prescriptions filled.
Read More
The U.S. Food and Drug Administration said it would not take enforcement action—for now—against pharmacies making their own versions of weight-loss drugs based on Eli Lilly’s tirzepatide.
Walgreens said Tuesday that its net loss swelled to more than $3 billion in the final quarter of the year, dragged down by U.S. retail and pharmacy sales.
America’s drugstores are testing smaller locations and more ways to offer care as price-sensitive shoppers look elsewhere.
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood sugar and take off weight.
A ransomware gang once thought to have been crippled by law enforcement has snarled prescription processing for millions of Americans over the past week, forcing some to choose between paying prices hundreds or thousands of dollars above their usual insurance-adjusted rates or going without lifesaving medicine.
VillageMD, a subsidiary of Chicago-based pharmacy giant Walgreens Boots Alliance, is closing more than 60 primary care clinics in five markets, including nine practices in northern Indiana and four in central Indiana.
The biggest U.S. drugstore chain aims to make the payment system more transparent by using a formula based on a drug’s cost, a fixed markup, and a fee that reflects the value of the pharmacy services, the company said Tuesday.
Organizers say retail pharmacists are not looking for more pay or vacation time. The protest is more about giving employees the ability to do their jobs safely.
In recent years, drugstores have struggled to fill open pharmacist and pharmacy technician positions, even as many have raised pay and dangled signing bonuses.
About 99% of pharmacists who responded to a recent survey by the American Society of Health System Pharmacists said they are experiencing drug shortages. About a third said the shortages are leading to rationing, delaying or canceling treatments or procedures.
Pure Pharmacy plans to spend about $4.5 million to lease and equip about 21,000 square feet near the Indianapolis Metropolitan Airport, Fishers officials said.
The decision comes after Attorney General Todd Rokita and 19 other attorneys general threatened legal action if the pharmacy company sells the pills by mail.
CVS Health is seeking to buy Oak Street Health, which runs clinics that specialize in treating Medicare Advantage patients.
The announcement comes as COVID-19 cases, hospitalizations and deaths are rising again, although they remain near their lowest levels since the coronavirus outbreak began in 2020.
A series of federal and state actions are putting the $400 billion PBM industry under a spotlight.
The consumer protection agency said Tuesday that that it will order the nation’s largest PBMs to provide a range of information and records detailing how they do business.
The partners are on the prowl to buy hundreds of primary care medical practices.
The company said Thursday that it will close about 300 stores a year for the next three years, nearly a tenth of its roughly 10,000 retail locations as it reduces store count density in some places.
A new report submitted to the Indiana Legislative Council calls for the regulation of “white bagging,” a practice that requires hospitals to buy drugs from an outside pharmacy, which delivers them premixed ahead of time of the patient’s visit. It is a growing practice, aimed at lowering the cost of care, but many providers say it can compromise care.
Health care practitioners and insurers are fighting over the hefty prices hospitals charge for specialty drugs to treat patients with cancer, vision loss, low white-blood-cell count and other serious diseases.
